Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAPOR-C: Feasibility of Volatile vs Propofol Anaesthesia in Cancer Surgery
NCT04074460Phase 4Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Aug 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propofol in breast cancer, colorectal cancer (CRC), lung cancer, prostate cancer (PCa), melanoma, sponsored by Peter MacCallum Cancer Centre. Started Aug 2017; status: completed.
02
Drugs
propofol
03
Conditions
breast cancercolorectal cancer (CRC)lung cancerprostate cancer (PCa)melanoma
Beyond the preview
Go deeper on NCT04074460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04074460.